{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Autonomix Medical, Inc."},"Symbol":{"label":"Symbol","value":"AMIX"},"Address":{"label":"Address","value":"21 WATERWAY AVE,SUITE 300, THE WOODLANDS, Texas, 77380, United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Autonomix, we're developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pancreatic cancer pain and pancreatitis pain."},"CompanyUrl":{"label":"Company Url","value":"https://www.autonomix.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bradley A. Hauser","title":"President & Chief Executive Officer"},{"name":"Landy Toth","title":"Chief Technology Officer"},{"name":"Robert Schwartz","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}